Company Update (NYSE:JNJ): Johnson & Johnson Announces Further Patent and Trademark Office Action Related to REMICADE®

[PR Newswire] – NEW BRUNSWICK, N.J., April 29, 2015 /PRNewswire/ — Johnson & Johnson (JNJ) today announced receipt of a further action from the United States Patent and Trademark Office (PTO) regarding the . . . → Read More: Company Update (NYSE:JNJ): Johnson & Johnson Announces Further Patent and Trademark Office Action Related to REMICADE® Similar Articles: Market Update: The Procter & Gamble Company (NYSE:PG) – Strong dollar squeezes company earnings Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Host Investor Conference Call on First-Quarter Results Company Update (NYSE:UNH): UnitedHealth CEO predicts growth across the company in 2015